All Metrics
STE Valuation Metrics
STE Stock Price Metrics
STE Dividend Metrics
STE Growth Rate Metrics
STE Discounted Cash Flow Metrics
| Fair Value Price | $273.95 |
| Margin of Safety | 30.08% |
STE Revenue Metrics
STE PE Ratio Metrics
| PE Ratio | 26.56 |
| PE Ratio Avg TTM | 34.67 |
| PE Ratio Avg 3Y | 42.56 |
| Current VS TTM Avg | -23.39% |
| Current VS 3Y Avg | -37.59% |
| Current VS 5Y Avg | -49.08% |
STE PS Ratio Metrics
| PS Ratio | 3.49 |
| PS Ratio Avg TTM | 4.13 |
| PS Ratio Avg 3Y | 4.36 |
| Current VS TTM Avg | -15.47% |
| Current VS 3Y Avg | -19.98% |
| Current VS 5Y Avg | -18.74% |
STE PB Ratio Metrics
| PB Ratio | 2.88 |
| PB Ratio Avg TTM | 3.35 |
| PB Ratio Avg 3Y | 3.47 |
| Current VS TTM Avg | -14.14% |
| Current VS 3Y Avg | -16.97% |
| Current VS 5Y Avg | -14.85% |
STE Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 21.31 |
| PFCF Ratio Avg TTM | 25.79 |
| PFCF Ratio Avg 3Y | 33.10 |
| Current VS TTM Avg | -17.36% |
| Current VS 3Y Avg | -35.62% |
| Current VS 5Y Avg | -47.24% |
STE Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 0.29 |
| Debt/Equity Ratio Avg TTM | 0.30 |
| Debt/Equity Ratio Avg 3Y | 0.41 |
| Current VS TTM Avg | -3.26% |
| Current VS 3Y Avg | -29.15% |
| Current VS 5Y Avg | -36.15% |
STE PEG Ratio Metrics
| PEG Ratio | 1.03 |
| PEG Ratio Avg TTM | 0.80 |
| PEG Ratio Avg 3Y | 0.61 |
| Current VS TTM Avg | +27.95% |
| Current VS 3Y Avg | +68.85% |
| Current VS 5Y Avg | +68.85% |
STE FCF Yield
| FCF Yield | 4.69% |
| FCF Yield Avg TTM | 3.90% |
| FCF Yield Avg 3Y | 3.13% |
| Current VS TTM Avg | +20.25% |
| Current VS 3Y Avg | +49.93% |
| Current VS 5Y Avg | +74.59% |
STE Earnings Yield
| Earnings Yield | 3.77% |
| Earnings Yield Avg TTM | 2.92% |
| Earnings Yield Avg 3Y | 2.22% |
| Current VS TTM Avg | +28.96% |
| Current VS 3Y Avg | +70.00% |
| Current VS 5Y Avg | +93.07% |
STE EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 20.30 |
| Ev/Ebit Ratio Avg TTM | 26.21 |
| Ev/Ebit Ratio Avg 3Y | 28.22 |
| Current VS TTM Avg | -22.55% |
| Current VS 3Y Avg | -28.05% |
| Current VS 5Y Avg | -51.17% |
STE EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 12.24 |
| Ev/Ebitda Ratio Avg TTM | 17.31 |
| Ev/Ebitda Ratio Avg 3Y | 17.67 |
| Current VS TTM Avg | -29.29% |
| Current VS 3Y Avg | -30.71% |
| Current VS 5Y Avg | -46.55% |
STE EV/Assets Ratio Metrics
| Ev/Assets Ratio | 2.08 |
| Ev/Assets Ratio Avg TTM | 2.41 |
| Ev/Assets Ratio Avg 3Y | 2.36 |
| Current VS TTM Avg | -13.86% |
| Current VS 3Y Avg | -11.95% |
| Current VS 5Y Avg | -7.97% |
STE EV/Sales Ratio Metrics
| Ev/Sales Ratio | 3.77 |
| Ev/Sales Ratio Avg TTM | 4.44 |
| Ev/Sales Ratio Avg 3Y | 4.84 |
| Current VS TTM Avg | -15.02% |
| Current VS 3Y Avg | -22.05% |
| Current VS 5Y Avg | -21.55% |
STE Current Ratio Metrics
| Current Ratio | 2.09 |
| Current Ratio Avg TTM | 2.22 |
| Current Ratio Avg 3Y | 2.29 |
| Current VS TTM Avg | -5.95% |
| Current VS 3Y Avg | -8.81% |
| Current VS 5Y Avg | -6.31% |
STE Quick Ratio Metrics
| Quick Ratio | 1.54 |
| Quick Ratio Avg TTM | 1.57 |
| Quick Ratio Avg 3Y | 1.53 |
| Current VS TTM Avg | -1.74% |
| Current VS 3Y Avg | +0.56% |
| Current VS 5Y Avg | +2.17% |
STE ROIC Metrics
| ROIC | 8.47% |
| ROIC Avg 3Y | 7.13% |
| ROIC Avg 5Y | 6.49% |
| Current VS 3Y Avg | +18.88% |
| Current VS 5Y Avg | +30.44% |
| Current VS 10Y Avg | +37.42% |
STE Return on Assets Metrics
| ROA | 7.31% |
| ROA Avg TTM | 6.68% |
| ROA Avg 3Y | 4.44% |
| Current VS TTM Avg | +9.35% |
| Current VS 3Y Avg | +64.45% |
| Current VS 5Y Avg | +69.02% |
STE Return on Equity Metrics
| ROE | 10.93% |
| ROE Avg TTM | 10.12% |
| ROE Avg 3Y | 7.00% |
| Current VS TTM Avg | +8.00% |
| Current VS 3Y Avg | +56.14% |
| Current VS 5Y Avg | +56.25% |
STE Net Profit Margin Metrics
| Net Profit Margin | 13.87% |
| Net Profit Margin Avg TTM | 12.50% |
| Net Profit Margin Avg 3Y | 11.83% |
| Current VS TTM Avg | +10.97% |
| Current VS 3Y Avg | +17.27% |
| Current VS 5Y Avg | +28.84% |
Last Updated: Friday, June 26, 2026
About STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Daniel A. Carestio